Kinguin Affiliate Bestsellers

While the development will get children living in India at par with other countries prioritizing COVID-19 vaccination for kids, the SEC recommendation has been, however, subject to some conditions. As per reports, Bharat Biotech will have to take care of some conditions before the vaccine gets a full go-ahead for use:

“The developer of Covaxin will continue the study as per Whole Virion, Inactivated CoronaVirus Vaccine the approved clinical trial protocol”

Become a football legend with FIFA 22

Apart from this, the pharma major will also have to list prescribing information, vaccine factsheet, product characteristics, data on AEFI and AESI every 15 days for the first two months, in accordance with the Clinical Trials Rules mandated in India.

Source link